Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion type Assertion NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_head.
- NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion description "[The frequency of HLA-DR11 was increased in HCV carriers, compared with patients with end-stage liver disease (ESLD) (corrected P value [Pc],.0002) and, especially, with patients who had HCC (Pc=.003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_provenance.
- NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion evidence source_evidence_literature NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_provenance.
- NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion SIO_000772 14999597 NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_provenance.
- NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion wasDerivedFrom befree-20140225 NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_provenance.
- NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_assertion wasGeneratedBy ECO_0000203 NP880061.RAugEhlGbdwpJqqmzoEz6fHKuCnKjd_IUiKlFzSskOk7g130_provenance.